|  | Cancer | Lung Cancer

Upper Lobe Lung Scarring in Non-Smokers: Etiologies and Diagnostic Approach

Upper lobe-predominant pulmonary fibrosis in non-smokers suggests specific etiologies distinct from usual interstitial pneumonia (UIP)/idiopathic pulmonary fibrosis (IPF), which is basal and smoking-associated.

Key Etiologies

1. Sarcoidosis

  • Granulomatous inflammation; upper lobe predominance (especially right).
  • Bilateral hilar lymphadenopathy (BHL) common.
  • Symptoms: cough, dyspnea, fatigue; Löfgren syndrome (erythema nodosum, bilateral hilar adenopathy, arthritis, fever).
  • Diagnosis: CXR/CT (perilymphatic nodules), ACE level, bronchoscopy with transbronchial biopsy (non-caseating granulomas), PET-CT.

2. Chronic Hypersensitivity Pneumonitis (HP)

  • Repeated antigen exposure (birds, molds, chemicals).
  • Subacute/chronic: upper/mid-lung fibrosis, centrilobular nodules, air trapping, mosaic attenuation.
  • Serum precipitins, BAL lymphocytosis (>30%), inhalation challenge.

3. Tuberculosis (Post-TB Sequelae)

  • Upper lobe apical fibrosis, bronchiectasis, calcification.
  • History of TB (often remote); endemic areas.
  • Rule out reactivation (AFB smear/culture, NAAT).

4. Nontuberculous Mycobacteria (NTM)

  • M. avium complex (MAC), M. kansasii.
  • Lady Windermere syndrome (thin, elderly women): RML/lingular nodules/bronchiectasis.
  • Diagnosis: Sputum AFB culture ×3, NTM speciation.

5. Connective Tissue Disease–Associated ILD (CTD-ILD)

  • Rheumatoid arthritis, systemic sclerosis, Sjögren's, MCTD, polymyositis/dermatomyositis.
  • Patterns: NSIP (common), UIP, OP. Can be upper lobe predominant (e.g., RA-UIP, chronic HP-like).
  • Serologies: RF, anti-CCP, ANA, ENA panel, CPK.

6. Radiation Fibrosis

  • Prior thoracic RT (lymphoma, breast, lung cancer).
  • Geometric field match; latency 6–24 months; progressive.

7. Environmental/Occupational

  • Asbestos (lower lobe, pleural plaques), silica, beryllium, hard metal — usually lower lobe.
  • Upper lobe: rare; consider chronic beryllium disease (BeLPT), certain organic dusts.

8. Drug-Induced

  • Nitrofurantoin, methotrexate, amiodarone, bleomycin, checkpoint inhibitors.
  • Pattern variable; temporal association key.

9. Rare Genetic/Metabolic

  • Hermansky-Pudlak syndrome (albinism, bleeding, pulmonary fibrosis — upper lobe).
  • Gaucher, Niemann-Pick.

Diagnostic Algorithm

  1. HRCT chest (prone, expiratory) — pattern recognition.
  2. Multidisciplinary discussion (MDD) — pulmonologist, radiologist, rheumatologist, pathologist.
  3. Serologies, PFTs (restrictive + ↓DLCO), BAL, +/- surgical lung biopsy (if MDD indeterminate).

Accurate diagnosis dictates prognosis and therapy (immunosuppression for sarcoid/CTD/HP vs. antifibrotics for progressive fibrotic phenotype).

Lung Cancer - Related Articles